Sign up
Pharma Capital
Market: LSE
52-week High/Low: 114.00p / 76.75p
Sector: Pharma & Biotech
Market Cap: 290.12M

Circassia (CIR:LSE) is a speciality biopharmaceutical company focused on the development of novel immunotherapies. These are designed to treat a range of common allergies and autoimmune conditions by controlling patients’ inappropriate immune responses. Our most advanced product, Cat-SPIRE, has achieved highly impressive results in clinical studies, and is currently in the final phase of...

Circassia Pharmaceuticals

Interactive graph

col 3
col 4
col 5
col 6
View full CIR profile View Profile
View All

Market Reports Including CIR


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.